Transcatheter Left Atrial Appendage Occlusion in the DOAC Era

Affiliations

¹ Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California. Electronic address: price.matthew@scrippshealth.org.
² Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: https://twitter.com/docsaw.

Free article

Editorial

Matthew J Price et al. J Am Coll Cardiol. 2020.

Free article

. 2020 Jun 30;75(25):3136-3139.

doi: 10.1016/j.jacc.2020.05.019.

¹ Division of Cardiovascular Diseases, Scripps Clinic, La Jolla, California. Electronic address: price.matthew@scrippshealth.org.
² Division of Cardiology, Vancouver General Hospital, University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: https://twitter.com/docsaw.

No abstract available

Keywords: Amulet; DOAC; Watchman; atrial fibrillation; direct oral antagonist; left atrial appendage; oral anticoagulation; thromboembolism.

Comment on

Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P, Herman D, Neuzil P, Hala P, Taborsky M, Kala P, Poloczek M, Stasek J, Haman L, Branny M, Chovancik J, Cervinka P, Holy J, Kovarnik T, Zemanek D, Havranek S, Vancura V, Opatrny J, Peichl P, Tousek P, Lekesova V, Jarkovsky J, Novackova M, Benesova K, Widimsky P, Reddy VY; PRAGUE-17 Trial Investigators. Osmancik P, et al. J Am Coll Cardiol. 2020 Jun 30;75(25):3122-3135. doi: 10.1016/j.jacc.2020.04.067. J Am Coll Cardiol. 2020. PMID: 32586585 Clinical Trial.